Quantiferon TB gold-plus assays (reagents and controls) for the detection of mycobacterium tuberculosis.
Active Awarded Last action
- Contract number
- HT941026FE079
- Awardee
-
Qiagen, LLC UEI W2GLKC92ZH73
- Awarding agency
-
Defense Health Agency
Department of Defense
- Obligated
- $0
Award facts
- Contract value 0% obligated
- $97,179.00 Current and potential, with all options
- Completion date 5% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 325413 In-Vitro Diagnostic Substance Manufacturing
- Set-aside
- No set-aside
- Competition
- Not Competed under SAP Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Germantown, MD, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Health Agency issued a $97,179 delivery order to Qiagen, LLC on October 1, 2026, for QuantiFERON TB Gold-Plus assays (reagents and controls) for the detection of Mycobacterium tuberculosis, with an ultimate completion date of September 30, 2027.
Place of performance is Germantown, MD. The order is issued on a firm fixed price basis. No set-aside applies to this delivery order.
Quick answers
Who was awarded contract HT941026FE079?
HT941026FE079 was awarded to Qiagen, LLC by Defense Health Agency (Department of Defense) on October 1, 2026.
How much is contract HT941026FE079 worth?
The government has obligated $0 on HT941026FE079. Its current value, with exercised options, is $97,179.
Is contract HT941026FE079 an order under another contract?
Yes. HT941026FE079 is a delivery order under W81K0225DA026, an indefinite delivery contract.
Was contract HT941026FE079 competed?
The extent of competition for HT941026FE079 was not competed under sap.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award